| abstract |
The present invention belongs to the field of chemical medicine, specifically, a compound having a 9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene structure and capable of inhibiting hepatitis C virus activity Or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug thereof, as well as pharmaceutical compositions containing these compounds and applications of these compounds or compositions in the preparation of drugs. The compounds of the present invention have a good HCV inhibitory effect. [Chemical 1] |